Home › Myasthenia Gravis › California
Myasthenia Gravis clinical trials in California
19 studies for Myasthenia Gravis are looking for participants at sites in California.
Cities in California
- San Francisco5 studies
- Orange5 studies
- Mountain View4 studies
- Los Angeles3 studies
- Carlsbad3 studies
- Pasadena3 studies
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1028, Irvine
- Site Number - 1023, Los Angeles
- Site Number - 1029, Rancho Mirage
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Care Access Research, Pasadena
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT04951622A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Lucile Packard Children's Hospital Stanford, Palo Alto
- UCSF Benioff Children's Hospital, San Francisco
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Nov 4, 2026 · NCT05265273ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Neurology Center of Southern California, Carlsbad
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07673627Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Neurology Center of North Orange County, Fullerton
- The Neurology Group, Pomona
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Nov 3, 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Clinical Study Site, Pasadena
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 30, 2026 · NCT07647510A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06680037ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Profound Research LLC - Carlsbad, Carlsbad
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07294170Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- Ronald Reagan UCLA Medical Center, Los Angeles
- UC Irvine Medical Center, Orange
- Stanford Blood and Marrow Transplant, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06626919RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- University of California Irvine, Orange
- UC Davis, Department of Neurology, Sacramento
- University of California, San Francisco, San Francisco
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06359041Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07304154ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Profound Research LLC - Carlsbad, Carlsbad
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07284420Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- University of California Irvine Medical Center, Irvine
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06414954Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 64 · Women · Updated Aug 11, 2026 · NCT06940323Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Pasadena
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Aug 3, 2026 · NCT07596901KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Ronald Reagan UCLA Medical Center, Los Angeles
- University of California, Irvine, Orange
- Stanford University Medical Center, Palo Alto
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Fresno
- Clinical Trial Site, Orange
- Clinical Trial Site, Rancho Mirage
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565Vitaccess Real MG Registry
- UCI Health, Orange
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06064461From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.